Long-term considerations for patients successfully using weight loss injections include the recognition that these medications typically require ongoing use to maintain weight loss
Glucagon-like peptide-1 receptor agonists and gastrointestinal adverse events: a systematic review and meta-analysis [published online June 9, 2025]
Dosing and Monitoring Challenges The intricate action of triple agonists necessitates precise dosing and vigilant monitoring
Theyre highly effective, fast-acting, and wildly popular with prescription volumes growing over 300% since 2020
Benefits of Natural GLP-1 Alternatives Choosing a natural GLP-1 alternative means supporting your weight loss and metabolic health in a safer, gentler way
Eli Lilly is also developing orforglipron, an oral, non-peptide GLP-1 receptor agonist that aims to provide similar weight loss efficacy without the need for injections